Spiro Medical
Belleair Bluffs, US · Founded 2023 · 22 employees on LinkedIn · 3 known investors
Find your way into Spiro Medical
Sign up to see every warm intro you have to Spiro Medical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Spiro Medical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Spiro Medical is a clinical-stage medical device company developing neuromodulation therapies for severe, uncontrolled asthma and other respiratory conditions. The company targets the neurological mechanisms underlying respiratory disease to provide treatment options for patients who have not benefited from conventional therapies.
Founders & leadership
Board
Investors · 3
How we know: a partner's Signal profile · funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$39.1M disclosed across 2 rounds · 2023–2025
▶$37.1MraisedJan 2026 · 23 investors · Other Health CareRule 506(b)
- Claudio NessiDirector
- Brian MooneyExecutive Officer
- Rapha?l WisniewskiDirector
- Ray CohenDirector
- Xiangyu OuyangDirector
- Rinda SamaExecutive Officer, Director
- Offering amount
- $69.1M
- Amount sold
- $37.1M
- First sale
- Dec 2025
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
▶$2MraisedOct 2025 · 8 investors · Other Health CareRule 506(b)
- Brian MooneyDirector
- Rinda SamaExecutive Officer
- Offering amount
- $2M
- Amount sold
- $2M
- First sale
- Sep 2023
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Spiro Medical do?
- Spiro Medical is a clinical-stage medical device company developing neuromodulation therapies for severe, uncontrolled asthma and other respiratory conditions. The company targets the neurological mechanisms underlying respiratory disease to provide treatment options for patients who have not benefited from conventional therapies.
- Who are Spiro Medical's investors?
- Spiro Medical's investors include Andera Partners, Supernova Invest, Omega Funds.
- How much funding has Spiro Medical raised?
- Spiro Medical has disclosed $39.1M raised across 2 rounds.
- Where is Spiro Medical headquartered?
- Spiro Medical is headquartered in Belleair Bluffs, US.



